Analysis

Gold collapses after vaccine news further boosted risk appetite

GOLD

Spot gold collapsed on Monday, being so far down 4.8% for the day, in the biggest daily fall since early August.
The safe-haven metal was sold after news that test for coronavirus vaccine showed more than 90% prevention in a study that greatly boosted risk appetite on hopes in speeding the economic recovery from the pandemic.
Fresh fall has erased all pre-US election gains, with bears pressuring key supports at $1848 (lows of pullback from $2074 record high) and eyeing next pivot at $1836 (Fibo 38.2% of $1451/$2074 upleg).
Clear break of these levels would open way for deeper correction and sideline hopes for fresh attempts through psychological $2000 barrier.
Broken base of thick daily cloud  and a cluster of converged daily MA’s at $1900 zone mark key resistances which are expected to keep the upside protected and maintain bearish stance.
Daily studies turned to full bearish setup, adding to negative sentiment.

Res: 1881; 1900; 1914; 1927
Sup: 1848; 1836; 1805; 1782

 

 

Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers.


RELATED CONTENT

Loading ...



Copyright © 2024 FOREXSTREET S.L., All rights reserved.